|Zhuhai Essex Bio-Pharmaceutical||1998||Recombinant bovine basic fibroblast growth factor||
Burn and scald wounds: including shallow II degree and deep II degree wounds, granulation wounds and inhalation injuries.|
* Acute wounds: bruises, contusions, combined injuries and cuts.
* Surgical incisions: incisions of surgery, orthopedics, gynaecology (such as lateral episiotomy and cesarean incision), otolaryngology, urology and proctology.
* Chronic wounds: diabetic ulcers, vascular ulcers, radiochemotherapy ulcers, bedsores, fistulas, residual wounds and cervical erosions.
* Skin grafting: skin donor site, skin grafting site, skin flap handling.
* Other applications: after plastic surgery, skin resurfacing, dermabrasion, nevus removal and laser therapy wounds.
|SFDA Approval No.S10980077|
|1999||Recombinant bovine basic fibroblast growth factor Eye Drops||
* Various corneal defects and punctate keratopathy.|
* Recurrent punctate keratopathy in the shallow layer.
* Mild or moderate dry eye.
* Corneal operation and poor corneal healing after operation.
* Geographic (or nutritional) herpes simplex keratitis.
* Ballous keratitis.
* Corneal abrasion, mild and moderate chemical burns.
|SFDA Approval No.S19991022|
|2005||Recombinant bovine basic fibroblast growth factor Gel||
Treatment of various keratopathy, ocular traumas and foreign body removal.|
* Corneal transplantation and eye surface reconstruction.
* Dry eye: especially dry eye due to corneal injury.
* Cataract surgery (ECCE. Phaco etc.): restoration of endothelium and reduction of edema.
* Corneal refractive surgery: repair damaged corneas before surgery, repair damaged nerves after surgery and treat postoperative dry eye
|SFDA Approval No.S20050100|
|Beijing SL Pharmaceutical||2002||Lyophilized Recombinant Human Basic Fibroblast Growth Factor (rh-bFGF)||Chronic Cutaneous Ulcer and Burn Wounds||SFDA Approval No.S20020025|
|Nanhai Longtime Pharmaceutical||2004||Recombinant Human Basic Fibroblast Growth Factor for External Use||Chronic Cutaneous Ulcer and Burn Wounds||SFDA Approval No.S20040052|
|Shanghai Wanxing Bio-Pharmaceutical||2006||Lyophilized Recombinant Human Acidic Fibroblast Growth Factor For External Use||Chronic Cutaneous Ulcer and Burn Wounds||SFDA Approval No.S20060102|
|Guilin pavay gene Pharmaceutical||2002||Recombinant Human Epidermal Growth Factor Hydro Gel||Chronic Cutaneous Ulcer and Burn Wounds||SFDA Approval No.S20020111|
|Wuhan HITECK biological pharmaceutical||2006||Mouse nerve growth factor for injection||Peripheral nerve injury and peripheral neuropathy; Brain and spinal cord injury; Acute cerebrovascular disease, cerebral atrophy, Parkinson’s and Alzheimer’s disease.||SFDA Approval No.S20060051|